Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Bowater makes pounds 68m US deal

Gail Counsell
Friday 23 April 1993 18:02 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

BOWATER, the acquisitive print and packaging group, is buying Tower Packaging, a medical packaging and film products company in Illinois, from Baxter Healthcare of the US for dollars 105m (pounds 68m), writes Gail Counsell.

The purchase will be made by Bowater's US subsidiary, Rexham, with dollars 65m of cash payable on completion on 30 April and the remainder due in instalments of dollars 10m a year for four years.

Tower, which will be renamed DRG-Tower, specialises in products like surgical drapes and sterilisable bags and pouches. At the end of December the company had tangible net assets of dollars 27m, although the deal also includes patent and technology licences and a long-term supply agreement between Bowater and Baxter.

This is necessary because Tower was primarily a captive in-house supplier to Baxter, and as a result made an operating loss of dollars 2.6m in 1992.

But Michael Hartnall, Bowater's finance director, said that if its sales had been on the basis now agreed with Baxter - with which Tower does 85 per cent of its business - the company would have made a profit of about dollars 9m.

The move would boost Bowater's percentage share of the US medical packaging market 'from the high twenties to the low thirties', Mr Hartnall added. Bowater is already the largest supplier of medical packaging products in the US.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in